Blood Collection Market Size, Share & Trends Report

Blood Collection Market Size, Share & Trends Analysis Report By Product (Needles & Syringes, Blood Collection Tubes, Blood Bags, Others), By Application (Diagnostics, Treatment), By End-Use, And Segment Forecasts, 2019 - 2026

Report ID: GVR-1-68038-382-9
Number of Pages: 107
Format: Electronic (PDF)

Historical Range: 2015 - 2017
Industry:Healthcare

Market Segmentation

Blood Collection ProductOutlook (Revenue, USD Million, 2015 - 2026)
- Needles and Syringes
- Blood Collection Tubes
  - Serum-separating
  - EDTA
  - Heparin
  - Plasma-separating
- Blood Bags
- Others
Blood CollectionApplication Outlook (Revenue, USD Million; 2015 - 2026)
- Diagnostics
- Treatment
Blood Collection End-UseOutlook (Revenue, USD Million; 2015 - 2026)
- Hospitals
- Diagnostics centers
- Blood banks
- Others
Blood CollectionRegional Outlook (Revenue, USD Million, 2015 - 2026)
- North America
  - North America Product Outlook (Revenue, USD Million, 2015 - 2026)
    - Needles and Syringes
    - Blood Collection Tubes
      - Serum-separating
      - EDTA
      - Heparin
      - Plasma-separating
    - Blood Bags
    - Others
  - North America Application Outlook (Revenue, USD Million, 2015 - 2026)
    - Diagnostics
    - Treatment
  - North America End-Use Outlook (Revenue, USD Million, 2015 - 2026)
    - Hospitals
    - Diagnostics Centers
    - Blood Banks
    - Others
  - The U.S.
    - U.S. Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - U.S. Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - U.S. End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
  - Canada
    - Canada Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - CanadaApplication Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - CanadaEnd-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
- Europe
  - Europe Product Outlook (Revenue, USD Million, 2015 - 2026)
    - Needles and Syringes
    - Blood Collection Tubes
      - Serum-separating
      - EDTA
      - Heparin
      - Plasma-separating
    - Blood Bags
    - Others
  - Europe Application Outlook (Revenue, USD Million, 2015 - 2026)
    - Diagnostics
    - Treatment
  - Europe End-Use Outlook (Revenue, USD Million, 2015 - 2026)
    - Hospitals
    - Diagnostics Centers
    - Blood Banks
    - Others
  - UK
    - UK Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - UK Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - UK End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
  - Germany
    - Germany Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - Germany Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - Germany End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
  - Italy
    - Italy Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - Italy Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - Italy End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
  - Russia
    - Russia Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - Russia Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - Russia End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
  - Spain
    - Spain Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - Spain Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - Spain End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
- Asia Pacific
  - Asia Pacific Product Outlook (Revenue, USD Million, 2015 - 2026)
    - Needles and Syringes
    - Blood Collection Tubes
      - Serum-separating
      - EDTA
      - Heparin
      - Plasma-separating
    - Blood Bags
    - Otherss
  - Asia Pacific Application Outlook (Revenue, USD Million, 2015 - 2026)
    - Diagnostics
    - Treatment
  - Asia Pacific End-Use Outlook (Revenue, USD Million, 2015 - 2026)
    - Hospitals
    - Diagnostics Centers
    - Blood Banks
    - Others
  - China
    - China Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Otherss
    - China Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - China End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
  - Japan
    - Japan Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - Japan Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - Japan End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
  - India
    - India Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - India Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - India End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
  - South Korea
    - South Korea Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - South Korea Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - South Korea End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
  - Australia
    - Australia Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - Australia Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - Australia End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
  - Singapore
    - Singapore Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - Singapore Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - Singapore End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
- Latin America
  - Latin America Product Outlook (Revenue, USD Million, 2015 - 2026)
    - Needles and Syringes
    - Blood Collection Tubes
      - Serum-separating
      - EDTA
      - Heparin
      - Plasma-separating
    - Blood Bags
    - Otherss
  - Latin America Application Outlook (Revenue, USD Million, 2015 - 2026)
    - Diagnostics
    - Treatment
  - Latin America End-Use Outlook (Revenue, USD Million, 2015 - 2026)
    - Hospitals
    - Diagnostics Centers
    - Blood Banks
    - Others
  - Brazil
    - 巴西产品前景(收入、百万美元2015- 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - Brazil Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - Brazil End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
  - Mexico
    - Mexico Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - Mexico Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - Mexico End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
  - Argentina
    - Argentina Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - Argentina Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - Argentina End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
- MEA
  - MEA Product Outlook (Revenue, USD Million, 2015 - 2026)
    - Needles and Syringes
    - Blood Collection Tubes
      - Serum-separating
      - EDTA
      - Heparin
      - Plasma-separating
    - Blood Bags
    - Otherss
  - MEA Application Outlook (Revenue, USD Million, 2015 - 2026)
    - Diagnostics
    - Treatment
  - MEA End-Use Outlook (Revenue, USD Million, 2015 - 2026)
    - Hospitals
    - Diagnostics Centers
    - Blood Banks
    - Others
  - South Africa
    - 南非产品前景(收入,百万美元, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - South Africa Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - South Africa End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
  - UAE
    - UAE Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - UAE Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - UAE End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others
  - Saudi Arabia
    - Saudi Arabia Product Outlook (Revenue, USD Million, 2015 - 2026)
      - Needles and Syringes
      - Blood Collection Tubes
        
        Serum-separating
        
        EDTA
        
        Heparin
        
        Plasma-separating
      - Blood Bags
      - Others
    - Saudi Arabia Application Outlook (Revenue, USD Million, 2015 - 2026)
      - Diagnostics
      - Treatment
    - Saudi Arabia End-Use Outlook (Revenue, USD Million, 2015 - 2026)
      - Hospitals
      - Diagnostics Centers
      - Blood Banks
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2015 to 2026
Market estimates and forecast for product segments up to 2026
Regional market size and forecast for product segments up to 2026
Market estimates and forecast for application segments up to 2026
Regional market size and forecast for application segments up to 2026
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.